VANECK VECTORS BIOTECH ETF: (BBH)
(Delayed Data from NSDQ) As of Sep 23, 2016 03:59 PM ET
$118.57 USD
-0.60 (-0.50%)
Volume: 26,623
Zacks ETF Rank [?]: 3 - Hold 3
This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:
| Zacks Rank | Definition |
|---|---|
| 1 | Strong Buy |
| 2 | Buy |
| 3 | Hold |
| 4 | Sell |
| 5 | Strong Sell |
See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs
ETF Quote Details
| Previous Close | 119.17 |
| Open | 118.93 |
| Bid | 117.89 |
| Ask | 119.17 |
| Day Low-High | 118.57-119.76 |
| 52wk Low-High | 93.10-119.76 |
| Volume | 26,623 |
| NAV (month end) | 113.71 |
| Premium (+)/Discount (-) (month end) | +5.46 |
Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.
This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:
| Zacks Rank | Definition |
|---|---|
| 1 | Strong Buy |
| 2 | Buy |
| 3 | Hold |
| 4 | Sell |
| 5 | Strong Sell |
See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs
ETF Expense Ratio
| Expense Ratio | 0.35% |
| Dividend (Yield) | $0.34 (0.28%) |
| Issuer | VAN ECK |
Benchmark for BBH
MVIS US LISTED BIOTECH 25 INDEX
The MVIS US Listed Biotech 25 Index tracks the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.
Fund Summary for BBH
VANECK VECTORS BIOTECH ETF
The VanEck Vectors Biotech ETF replicates as closely as possible, before fees and expenses, the price and yield performance of MVIS US Listed Biotech 25 Index.